Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for pelvic inflammatory disease
ISRCTN51790058Phase 4Completed
- Sponsor
- Brighton and Sussex University Hospitals NHS Trust
- Start
- Nov 2011
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of azithromycin in Pelviabdominal infection (2 arms), sponsored by Brighton and Sussex University Hospitals NHS Trust. Primary endpoint: Clinical efficacy of treatment regimes. Started Nov 2011; status: completed.
02
Drugs
azithromycin
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on ISRCTN51790058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51790058.